Sedative Hypnotic Class Labeling Warns Of Sleep-Driving And “Complex” Behaviors
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA requests manufacturers of 13 sleep aids, including Ambien, Lunesta and Rozerem, to update labeling to advise of adverse events.